Search - tctmd.com

Displaying 941 - 960 of 1135

Sort: Relevancy | Date

News Daily News

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

December 10, 2013

Presentation

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

Presenter: A. Stazi

December 09, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

Caitlin E. Cox

November 01, 2013

Presentation TCT 2013

EUROMAX: Critical Appraisal and Clinical Implications

Presenter: Gregg Stone

October 30, 2013

Presentation TCT 2013

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Presenter: Philippe Gabriel Steg

October 30, 2013

Presentation TCT 2013

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Presenter: Sripal Bangalore

October 27, 2013

News Daily News

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

L.A. McKeown

October 04, 2013

News Daily News

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

L.A. McKeown

October 04, 2013

News Daily News

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Jason Kahn

October 04, 2013

News Daily News

Consecuencias de Hemorragias Menos Severas en Pacientes a Tratamiento con Dabigatran que en aquellos a Tratamiento con Warfarina

Jason Kahn

October 04, 2013

Presentation

Management and Outcomes of Major Bleeding During Treatment with Dabigatran or Warfarin

Presenter: A. Majeed

October 03, 2013

Presentation

Meta-analysis of Randomized Trials on Risk of MI from the Use of Oral Direct Thrombin Inhibitors

Presenter: Ramin Artang

October 01, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Daily News

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

L.A. McKeown

September 20, 2013

$A Direct Comparison of IV Enoxaparin with Unfractionated Heparin in Primary PCI$

Presentation

A Direct Comparison of IV Enoxaparin with Unfractionated Heparin in Primary PCI

Presenter: J.P. Collet

September 13, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

Presentation

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Presenter: Stephen D. Wiviott

August 20, 2013

News Daily News

桡动脉PCI加比伐卢定能够有效降低出血风险

L.A. McKeown

August 19, 2013

Advertisement

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

HORIZONS-AMI：使用比伐卢定减少出血仅为死亡率降低的部分原因

EUROMAX: Critical Appraisal and Clinical Implications

Featured Trial of the Day: EUROMAX: A Prospective, Randomized Trial of Ambulance Initiation of Bivalirudin vs. Heparin ± Glycoprotein IIb/IIIa Inhibitors in Patients with STEMI...

Antithrombin Therapy (GP IIb/IIIa inhibitors) in Patients with ACS and Those Undergoing PCI

Oral Direct Thrombin Inhibitors Linked to Increased MI Risk

Los Inhibidores Orales Directos de la Trombina se asocian a un Mayor Riesgo de IM

Fallout from Bleeding Less Severe in Patients on Dabigatran Compared with Warfarin

Consecuencias de Hemorragias Menos Severas en Pacientes a Tratamiento con Dabigatran que en aquellos a Tratamiento con Warfarina

Management and Outcomes of Major Bleeding During Treatment with Dabigatran or Warfarin

Meta-analysis of Randomized Trials on Risk of MI from the Use of Oral Direct Thrombin Inhibitors

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

Análisis refuerza el apoyo a la enoxaparina sobre la heparina en la PCI por STEMI

A Direct Comparison of IV Enoxaparin with Unfractionated Heparin in Primary PCI

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

桡动脉PCI加比伐卢定能够有效降低出血风险

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content